FDA CBE30 Approval Records for Methocarbamol at Evaric Pharmaceuticals

FDA CBE30 Approval Records for Methocarbamol at Evaric Pharmaceuticals

Regular price $69.00 USD
Regular price Sale price $69.00 USD
Sale Sold out
Original Request: We are requesting documentation on the CBE30 approval for Evaric Pharmaceuticals to manufacture Methocarbamol at their facility in Hauppauge, NY facility (establishment number 3013061208). NDC's relevant to this request are: 72865-0234-05, 72865-0234-01, 722865-0233-05, & 72865-0233-01; but records are being requested on any methocarbamol produced at the facility.
Tags: Pharma, EIR, 2024
  • Status: Pending Fast-Track Request
  • Delivery: Approximately 1 to 2 weeks when the FOIA office is operating at regular capacity

NOTE: This document is not currently in our library. Upon purchase, we will request the document from the FDA FOIA office. Learn more about Fast-Track Requests here.

View full details